TFF PharmaceuticalsTFFP
TFFP
About: TFF Pharmaceuticals Inc is a biopharmaceutical company focused on developing and commercializing drug products based on its patented Thin Film Freezing, or TFF, technology platform. It is focused on the development of inhaled dry powder drugs for the treatment of lung disorders.
Employees: 19
0
Funds holding %
of 6,740 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
11% more funds holding
Funds holding: 19 [Q1] → 21 (+2) [Q2]
6.8% more ownership
Funds ownership: 13.96% [Q1] → 20.76% (+6.8%) [Q2]
38% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 8
50% less capital invested
Capital invested by funds: $2.13M [Q1] → $1.07M (-$1.06M) [Q2]
Research analyst outlook
We haven’t received any recent analyst ratings for TFFP.
Financial journalist opinion
Charts implemented using Lightweight Charts™